| Title | Date |
|---|
| Surprising Phase II Clinical Trial Results of Oral Ibudilast Show Some Evidence of Neuroprotection But Little Impact Against Inflammation in MS | Mar 18, 2010 |
| Two New Studies Link Epstein-Barr Virus to Risk of Developing MS | Mar 16, 2010 |
| Trial of Low-Dose Naltrexone Finds Preliminary Benefit to Mental Health Quality of Life for People with MS | Mar 15, 2010 |
| FDA Approves Botox® for Treating Spasticity, or Tightness, in Upper Limbs | Mar 12, 2010 |
| UPDATE: CCSVI - International Scientific Panel Formed to Expedite Review of Submitted CCSVI Research Proposals | Mar 11, 2010 |
| UPDATE: Ampyra™, Symptomatic Medicine Approved by FDA to Improve Walking for People with All Types of MS, Now Available by Prescription | Mar 01, 2010 |
| MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Recruiting People at High Risk for MS Worldwide | Mar 01, 2010 |
| Gilenia – the Oral Drug for Relapsing MS Formerly Known as FTY720 – Receives Priority Review from FDA – Could take as little as six months for an approval decision | Feb 22, 2010 |
| Advanced Releases Offer First Glimpse of Many MS Studies To Be Presented at April AAN Medical Meeting | Feb 22, 2010 |
| Results of Phase II “CHOICE” Study Published, Showing that Daclizumab Reduced Disease Activity in Relapsing MS, and Revealing Novel Immune Mechanism | Feb 16, 2010 |
| UPDATE on Tysabri and PML: Sponsor and FDA Provide Information on Cases and Risks | Feb 13, 2010 |
| University at Buffalo Medical Center Issues a Release on Preliminary Findings of its Study of Venous Insufficiency Prevalence in MS | Feb 11, 2010 |
| Leaders from National MS Society Meet with Dr. Zamboni at NYU-hosted Scientific Presentation | Feb 09, 2010 |
| UPDATE: CCSVI or Blood Flow in the Brain and Venous Insufficiency in MS – Society Leaders Meet with Dr. Zamboni Today. Research Proposals Received from Around the World on February 9th Grant Request Deadline | Feb 09, 2010 |
| MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Recruiting People with Relapsing Forms of MS Worldwide | Feb 08, 2010 |
| MS Trial Alert: Recruiting Nationwide for Study of Copaxone in Patients with First Episode of Acute Optic Neuritis | Feb 02, 2010 |
| National MS Society Seeks Proposals for a Study on Risk Factors Influencing MS Progression | Jan 28, 2010 |
| Australian Study Questions Established Concepts of Early Disease Events In MS | Jan 28, 2010 |
| Positive Results Published on Clinical Trials of Oral FTY720 (Fingolimod) for Relapsing MS -- Novartis Applies to FDA and European Regulatory Agency for Approval | Jan 20, 2010 |
| Results Published from Phase 3 Study of Oral Cladribine in Relapsing-Remitting MS | Jan 20, 2010 |
| Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes | Jan 19, 2010 |
| MS Trial Alert: Investigators in Ohio Recruiting 24 People for Study of Autologous Mesenchymal Stem Cell Transplantation | Jan 06, 2010 |
| Crucial Evidence Supports Autoimmune Nature of Neuromyelitis Optica, an MS Mimic | Dec 15, 2009 |
| 2009: Substantial Progress Propelled MS Research Forward | Dec 15, 2009 |
| Positive Results Announced in Phase II Study of IV Ocrelizumab in Relapsing-Remitting MS | Dec 04, 2009 |
| MS Trial Alert: Investigators Worldwide Recruiting for Study of Antibody in Relapsing-Remitting MS | Dec 02, 2009 |
| Sponsor Receives “Refuse to File” Letter from the FDA for its Application Seeking Approval for Oral Cladribine -- Usually means agency deems application incomplete | Nov 30, 2009 |
| Flu Vaccines—2009-2010 | Nov 19, 2009 |
| Pregnancy Study Shows Increase in C-Sections and Slightly Lower Fetal Size among Women with MS | Nov 18, 2009 |
| New Data Support Early Interferon Treatment for Multiple Sclerosis | Nov 12, 2009 |
| Harvard Study Links Teen Obesity in Girls to Increased Risk of Developing MS | Nov 11, 2009 |
| Minimally Invasive Radiosurgery May Improve MS Facial Pain that Does Not Respond to Drugs | Nov 11, 2009 |
| Fast Forward Think Tank Explores Personalized Medicine and the Translation of High-Tech Lab Discoveries to Improving Treatment of MS | Nov 09, 2009 |
| Society-Funded Researchers Show that Early Relapses Link to MS Progression | Nov 05, 2009 |
| Results Published from Rituximab Study in Primary-Progressive MS | Oct 29, 2009 |
| 26 New Research Projects Launched Totaling $9.2 Million To Propel Multiple Sclerosis Research | Oct 26, 2009 |
| European Drug Agency to Weigh Risks/Benefits of Tysabri -- cites 23 cases of PML | Oct 23, 2009 |
| Researchers Show How Immune Attack May Directly Damage Nerve Fibers in MS | Oct 21, 2009 |
| Case report: Person treated with Tysabri for MS develops brain cancer (primary central nervous system lymphoma) | Oct 15, 2009 |
| Panel Recommends that FDA Approve Fampridine-SR (proposed name Amaya) for Symptomatic Treatment of MS (UPDATED) | Oct 14, 2009 |
| PreCISe Study Results – Showing Benefit of Copaxone® in People at High Risk for MS – Published | Oct 07, 2009 |
| Fast Forward Announces Collaborative Alliance with the Accelerated Cure Project, a National Nonprofit Organization, to Support ACP’s Tissue Repository Program | Sep 30, 2009 |
| Sponsor applies to FDA for approval of oral Cladribine for relapsing MS – approval would mean first oral disease-modifying therapy for MS (UPDATED) | Sep 30, 2009 |
| Positive Results Announced from Phase 3 Trial of Fingolimod Pills in Relapsing MS | Sep 30, 2009 |
| Therapeutic Strategies for MS and More Highlighted at ECTRIMS Conference (UPDATED) | Sep 22, 2009 |
| Update on Tysabri and PML | Sep 18, 2009 |
| MS Trial Alert: Investigators Recruiting for Study of Duloxetine Hydrochloride to Treat Neuropathic Pain in MS | Sep 14, 2009 |
| International Team Refutes Finding of Evidence of Epstein-Barr Virus in Brains of People with MS | Aug 31, 2009 |
| MS Trial Alert: Investigators Recruiting 1260 People with MS for Study of PEGylated Interferon Beta-1a | Aug 31, 2009 |
| Fast Forward Contracts With IntraLinks to Accelerate and Facilitate Its Drug Funding Decisions | Aug 27, 2009 |
| New Studies Associate Smoking with Tissue Damage and Disease Development in People with MS | Aug 27, 2009 |
| National MS Society-Funded Study Shows Diabetes Drug Improves Mice with MS-Like Disease | Aug 27, 2009 |
| Fast Forward, LLC and Amplimmune, Inc. Join Forces To Speed New Treatment to People With MS | Aug 25, 2009 |
| Drug Used for High Blood Pressure Shows Benefits in Treating MS-like Disease in Mice | Aug 18, 2009 |
| UPDATED New Brand of Interferon Beta for Treating MS Approved by FDA | Aug 18, 2009 |
| Sponsor Reports Positive Results of Clinical Trial of Zenvia™ for Pseudobulbar Affect (Uncontrollable Laughing and/or Crying) | Aug 14, 2009 |
| MS-like Disease in Mice Suppressed by Fusing Two Immune Proteins | Aug 14, 2009 |
| Care Given to People with MS by Family Members Presents Unique Challenges - Study funded by National MS Society points to need for respite and mental health support for family care givers | Aug 11, 2009 |
| Disappointing Results from Phase 3 Clinical Trial of Dirucotide (MBP8298) in Secondary-Progressive MS -- Companies announce halt to ongoing trials of dirucotide in MS | Jul 29, 2009 |
| NIH Deepens Investment in Combination Study of MS Drugs | Jul 20, 2009 |
| Study Adds Evidence that Smoking Worsens MS, and Quitting May Help | Jul 16, 2009 |
| MS Trial Alert: Small Study Recruiting People with MS and Spasticity to Compare IPX056 (Extended-release Baclofen) and Immediate-release Baclofen | Jul 14, 2009 |
| Team Funded by National MS Society’s Promise: 2010 Campaign Identifies Key Signals in Myelin Repair | Jul 13, 2009 |
| Clinical Trial of Oral CDP323 in Relapsing MS Discontinued | Jul 13, 2009 |
| “Benign” Course of MS Evaluated with MRI and Other Imaging Methods by European Collaborators | Jul 08, 2009 |
| MS Trial Alert: Recruiting Patients for Study on How Adhering to Therapy Impacts MS | Jun 25, 2009 |
| Two Studies Report Finding New Genes and Gene Regions that Make People Susceptible to MS | Jun 22, 2009 |
| Two Medical Meetings (ACTRIMS and CMSC) Focus on MS Risk Factors and Quality of Life Issues | Jun 10, 2009 |
| Study: Breastfeeding May Reduce Likelihood of Postpartum MS Attacks | Jun 10, 2009 |
| MS Trial Alert: Sites in Ohio, Texas, and Washington Recruiting for a Small Study of Autologous ("Self") Hematopoietic Stem Cell Transplant Underway | May 26, 2009 |
| Positive Clinical Trial Results Take Center Stage at American Academy of Neurology Meeting (UPDATED) | May 22, 2009 |
| Clinical Trials in Multiple Sclerosis 2009 | May 19, 2009 |
| Detecting Nervous System Repair in MS: International Workshop Findings Published | May 18, 2009 |
| Fast Forward, LLC, Seeking Proposals in Early Stage Drug Development for MS | May 07, 2009 |
| Fast Forward, LLC and Provid Pharmaceuticals Announce Partnership for Development of PV-267, A Unique Compound Intended to Redirect the Abnormal Immune Response In Multiple Sclerosis | May 05, 2009 |
| Dr. David Miller, Pioneer in MS Imaging, Awarded 2009 John Dystel Prize | Apr 28, 2009 |
| Is it Multiple Sclerosis or a Look-Alike? International Society Task Force Offers Guidelines for Diagnosing MS and its Mimics | Apr 23, 2009 |
| New Study Reports Reduced Overall Cancer Risk in People with MS | Mar 30, 2009 |